[1] |
YANG Shuzhen, ZHU Chuanming, LI Yan, LIU Tingting, WANG Hongxing, ZHENG Xiaofeng.
Applicability of 99mTc-Ethyl Cysteinate Dimer in the Examination of Ischemic Cerebrovascular Diseases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 313-315.
|
[2] |
LIU Nannan, XI Yalin, CHEN Zhe.
One Case of Adrenocortical Insufficiency Caused by Cadonilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 109-112.
|
[3] |
SUN Xuelin, ZHANG Pan, HU Xin.
Pharmaceutical care of a case of severe ulcerative colitis treated with vedolizumab
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 782-785.
|
[4] |
YANG Baochun, SUN Xin, YANG Xin, WU Lin, WANG Liping.
Pharmaceutical care for a patient with urinary tract infection and drug fever
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 572-573.
|
[5] |
ZHUANG Hongyan, LIU Shanshan, GUO Wei, XUE Chunmiao, HE Yue, ZHAO Yan.
Chinese and western medicine pharmaceutical care for one diabetic foot patient with multiple complications
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 103-106.
|
[6] |
LIANG He, MENG Guangyi, ZHONG Liqiu, ZHOU Lijuan, PANG Jiarong.
Influencing factors of coagulation abnormalities induced by cefoperazone sodium and sulbactam sodium in patients with ischemic cerebrovascular disease
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 87-90.
|
[7] |
WU Hong, LI Xin, HAN Feng.
Rationality and Safety of New Monoclonal Antibody Antitumor Drugs Used Clinically in a Tertiary Tumor Hospital
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 960-964.
|
[8] |
JIANG Li, BI Xiaoting, LI Bo.
Medication Adjustment of One Case of Crohn's Disease with Peritoneal Abscess by Clinical Pharmacists
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 613-616.
|
[9] |
WEN Yu, CHEN Yunyan, ZHANG Qiuping.
Pipeline Service System Model in Control of High-risk Drugs
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 926-929.
|
[10] |
YU Ying, LIU Dongling, CHEN Fei, ZHANG Fan.
Pareto Diagram Analysis of Intervention in Irrational Medical Orders for Inpatients of Endocrinology
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 921-925.
|
[11] |
CAI Jiangxia, AN Linna.
Pharmacological Practice for One Case of Advanced Lung Cancer with Bronchial Asthma and Pulmonary Infection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(8): 492-495.
|
[12] |
CHEN Chao,GUO Dai-hong, XUE Wan-guo, LIU Dong-jie, LIU Gui-yang, ZHU Man .
Development of Alarming System to Actively Monitor and Assess the Adverse Drug Events in Hospitalized Patients
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(7): 411-414.
|
[13] |
CHI Xue-jie, SUN Rong .
Research Development on the Protection of the Active Constituent of Ligusticum chuanxiong Hort againstIschemic Cerebrovascular Disease
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(6): 355-357.
|
[14] |
ZHONG Xue, ZHANG Ya-tong, HU Xin ,CHENG Gang.
Pharmaceutical Care of One Patient with Suspected Secondary Hypertension
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(2): 119-121.
|
[15] |
SHEN Zheng-lin ,YUAN Ming-qing .
Pharmaceutical Care for One Case of Severe Adverse Reaction Induced by Irinotecan Combined with Chemotherapy
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(11): 696-697.
|